USPTO serial 97201376
WELLVII VITAL DETECT
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, CYNTHIA RINALDI
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with WELLVII VITAL DETECT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Laura A. Genovese
Laura A. Genovese K & G LAW LLC602 S. BETHLEHEM PIKE, BLDG BAMBLER, PA 19002United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Apparatus for blood analysis; Blood glucose meter; Blood oxygen monitors; Blood pressure measuring apparatus; Blood pressure monitors; Blood pressure transducers; Blood pressure and diabetic diagnostic medical devices; Blood pretreatment apparatus and instruments; Devices for measuring blood sugar; Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Electronic temperature monitors for medical use; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory event; Medical apparatus and instruments for use in positron emission tomography (PET) imaging used to monitor brain, heart and metabolic functions; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of electronics for transmitting monitored data through the Internet, as a component of the medical devices; Medical instruments for measuring and displaying vital signs, blood properties and respiratory events; Medical apparatus for monitoring vital signs of patients; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Patient medical monitors for monitoring systolic blood pressure, diastolic blood pressure, blood glucose levels, blood perfusion, pulse rate, heart rate, blood oxygenation saturation (SPO2), heart rate variability, respiration rate, core body temperature, weight and electrocardiogram (ECG); Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Arterial blood pressure measuring apparatus; Health monitoring devices consisting of blood pressure monitors, thermometers and pedometers; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood properties and respiratory events; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 2, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 2, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 2, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 2, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 2, 2025 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 25, 2025 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jun 25, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 10, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 10, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Dec 9, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 11, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 11, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 25, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 25, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 25, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 25, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 4, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 2, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 2, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 2, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 23, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 21, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 21, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 21, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 27, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 1, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 1, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 12, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 26, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 26, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 26, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 26, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 26, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 7, 2022 | NWAP | NEW APPLICATION ENTERED | — |